985.08
price up icon0.80%   7.83
after-market Handel nachbörslich: 984.94 -0.14 -0.01%
loading

Finanzdaten der Lilly Eli Co-Aktie (LLY)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
9.61%
19,292.00
17,600.80 15,557.70 12,728.50 13,532.80
Cost Of Revenue
12.08%
3,371.70
3,008.30 2,447.80 2,224.20 2,403.80
Gross Profit
9.10%
15,920.30
14,592.50 13,109.90 10,504.30 11,129.00
Operating Expenses
3.99%
7,654.10
7,360.10 6,333.50 7,048.20 6,090.30
Benefits Costs and Expenses
6.34%
11,025.80
10,368.40 8,781.30 9,272.40 8,494.10
Costs And Expenses
6.34%
11,025.80
10,368.40 8,781.30 9,272.40 8,494.10
Operating Income/Loss
14.29%
8,266.20
7,232.40 6,776.40 3,456.10 5,038.70
Nonoperating Income/Loss
18.63%
-108.30
-133.10 -90.60 -239.00 -110.10
Income/Loss From Continuing Operations Before Tax
14.29%
8,266.20
7,232.40 6,776.40 3,456.10 5,038.70
Income Tax Expense/Benefit
1.30%
1,628.50
1,649.90 1,115.90 696.80 628.90
Income/Loss From Continuing Operations After Tax
18.90%
6,637.70
5,582.50 5,660.50 2,759.30 4,409.80
Net Income/Loss
18.90%
6,637.70
5,582.50 5,660.50 2,759.30 4,409.80
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
100.06%
-0.50
896.90 897.90 898.70 -0.295
Diluted Average Shares
100.04%
-0.40
898.80 899.80 900.60 -0.341
Basic Earnings Per Share
18.97%
7.40
6.22 6.30 3.07 4.90
Diluted Earnings Per Share
19.00%
7.39
6.21 6.29 3.06 4.88
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
drug_manufacturers_general JNJ
$241.52
price down icon 0.21%
$219.68
price down icon 2.52%
drug_manufacturers_general AZN
$189.90
price down icon 1.35%
drug_manufacturers_general NVS
$153.44
price down icon 0.53%
drug_manufacturers_general MRK
$115.61
price down icon 0.26%
Kapitalisierung:     |  Volumen (24h):